サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623502

除細動器の世界市場規模：エンドユーザー別、製品別、地域別、範囲および予測

Global Defibrillators Market Size By End User(Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets), By Product(Implantable Cardioverter Defibrillators (ICDS), External Defibrillators), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.95円
除細動器の世界市場規模：エンドユーザー別、製品別、地域別、範囲および予測
出版日: 2024年09月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

除細動器の市場規模と予測

除細動器市場規模は、2020年に108億8,000万米ドルと評価され、2021年から2028年にかけてCAGR 5.60%で成長し、2028年には167億2,000万米ドルに達すると予測されます。

対象疾患のリスクが最も高い高齢人口の増加、心疾患の発生率の上昇、公共アクセス除細動器の提供への注目の高まりが、予測される数年間にわたり除細動器市場を牽引すると予想されます。除細動器の世界市場レポートは、市場の総合的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

除細動器市場の定義

除細動器は、無脈性心室頻拍、不整脈、心室細動などの重篤な状態において、患者の心臓に治療用ショックを与えるために使用される電子機器です。電気ショックは心臓の筋肉を脱分極させ、正常な電気インパルスを回復させる。生命を脅かす不整脈に苦しむ人々の突然死を防ぐことができます。除細動器のエンドユーザーは、病院、診療所、心臓センター、プレ病院、公共アクセス市場、在宅医療、代替医療市場です。製品によって、植込み型除細動器（ICD）、体外式除細動器、手動式体外式除細動器、装着型除細動器（WCD）に分類されます。

除細動器の世界市場概要

対象疾患のリスクが最も高い高齢者人口の増加と、公共アクセス除細動器の提供に対する注目の高まりが、予測される数年間にわたり除細動器市場を牽引すると予想されます。また、除細動器に関するトレーニングと意識向上プログラム、心疾患の発生率の上昇が、今後数年間の市場の後押しになると予想されます。さらに、CRT-Ds、S-ICDs、MRI対応ICDsの開発も進んでいます。

市場成長の妨げとなる抑制要因や課題も存在します。突然の心停止（SCA）に対する認識不足や製品の不具合などの要因が市場抑制要因として作用する可能性が高いです。

目次

第1章 除細動器の世界市場イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 除細動器の世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 規制の枠組み

第5章 除細動器の世界市場：エンドユーザー別

  • 病院、クリニック、心臓センター
  • プレ病院
  • 公共アクセス市場
  • 在宅医療
  • 代替医療市場

第6章 除細動器の世界市場：製品別

  • 植込み型除細動器（ICD）
    • 植込み型除細動器（T-ICD）
    • 皮下植込み型除細動器（S-ICD）
  • 体外式除細動器
    • 自動体外式除細動器（AED）
  • 手動式体外式除細動器
  • 装着型除細動器（WCD）

第7章 除細動器の世界市場：地域別

  • 概要
  • 北米地域の市場推計・予測、2012年～2025年
    • 米国
    • カナダ
    • メキシコ
  • 欧州地域の市場推計・予測、2012年～2025年
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋地域の市場推計・予測、2012年～2025年
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ地域の市場推計・予測、2012年～2025年
    • ブラジル
    • アルゼンチン
  • 世界のその他の地域の市場推計・予測、2012年～2025年

第8章 除細動器の世界市場競合情勢

  • 概要
  • 企業市場シェア
  • ベンダー情勢
  • 主な開発戦略

第9章 企業プロファイル

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare
  • Zoll Medical Corporation
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation
  • Sorin Group
  • Nihon Kohden Corporation

第10章 付録

  • 関連レポート
目次
Product Code: 23941

Defibrillators Market Size And Forecast

Defibrillators Market size was valued at USD 10.88 Billion in 2020 and is projected to reachUSD 16.72 Billion by 2028, growing at aCAGR of 5.60% from 2021 to 2028.

The growing geriatric population having the highest risk of target diseases, rising incidence of cardiac diseases, and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. The Global Defibrillators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Defibrillators Market Definition

A defibrillator is an electronic device used to deliver a therapeutic shock to a patient's heart in serious conditions like pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock depolarizes the heart muscles and restores its normal electric impulse. It can prevent sudden death among people suffering from life-threatening arrhythmia. End-Users of defibrillators are Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. Based on the product, they are classified into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS).

Global Defibrillators Market Overview

The growing geriatric population having the highest risk of target diseases and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. Also, training & awareness programs on defibrillators and the rising incidence of cardiac diseases expects a boost to the market in the coming years. Additionally, the development of CRT-Ds, S-ICDs, and MRI-compatible ICDs

There are certain restraints and challenges faced which can hinder the market growth. Factors such as lack of awareness about the sudden cardiac arrest (SCA) and product failures are likely to act as market restraints.

Global Defibrillators Market: Segmentation Analysis

The Global Defibrillators Market is Segmented into End User, Product, And Geography.

Defibrillators Market by End-User

Hospitals, Clinics, & Cardiac Centers

Pre-Hospitals

Home Care

Alternate Care Markets

Based on the end-user, the market is bifurcated into Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. The Hospitals, Clinics, & Cardiac Centers segment is predicted to hold the largest market share. The factors can be attributed to the availability of reimbursements facilities and upsurge in the number of cardiac implant procedures.

Defibrillators Market by Product

Implantable Cardioverter Defibrillators (ICDS)

Implantable Cardioverter Defibrillators (T-ICDS)

Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)

Dual-Chamber ICDS

Single-Chamber ICDS

Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

External Defibrillators

Automated External Defibrillators (AEDS)

Semi-Automated External Defibrillators

Fully Automated External Defibrillators

Manual External Defibrillators

Wearable Cardioverter Defibrillators (WCDS)

Based on the product, the market is bifurcated into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS). The Implantable Cardioverter Defibrillators (ICDS) segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) & S-ICD systems across the globe and the development of technologically advanced devices with extended longevity.

Defibrillators Market by Geography

Based on regional analysis, the Global Defibrillators Market is classified into

North America

Europe

Asia Pacific

Rest of the world

The largest share in the market will be dominated by North America owing to the technological advancements, increasing the geriatric population, and the prevalence of cardiac diseases in this region.

Key Players

The Major Players in the market are as follows:

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare (A Division of Koninklijke Philips N.V.)
  • Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
  • orin Group (Now Livanova PLC)
  • Nihon Kohden Corporation

These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Key Developments

Product Launches and Product Expansions

  • On April 2020, Philips, a health technology company, announced that the Emergency Care and Resuscitation (ECR) business is recommencing the US manufacturing and shipping of external defibrillators. The company notified that the US Food and Drug Administration (FDA) had lifted the restrictions imposed on the manufacturing and distribution of defibrillators in the US.
  • On March 2021, The Rankin government announced that all public schools in Nova Scotia would be provided automated external defibrillators. The government invested USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.
  • On July 2021, ZOLL Medical Corporation announced that the company had received clearance from FDA 510(k) to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provided clinical decision support for managing patients with TBI and was available in international markets, but it is now available in the U.S. market with the FDA clearance.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 Global Defibrillators Market, By End User

  • 5.1 Hospitals, Clinics, & Cardiac Centers
  • 5.2 Pre-Hospitals
  • 5.3 Public Access Markets
  • 5.4 Home Care
  • 5.5 Alternate Care Markets

6 Global Defibrillators Market, By Product

  • 6.1 Implantable Cardioverter Defibrillators (ICDS)
    • 6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
    • 6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
    • 6.1.1.2 Dual-Chamber ICDS
    • 6.1.1.3 Single-Chamber ICDS
    • 6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
  • 6.2 External Defibrillators
    • 6.2.1 Automated External Defibrillators (AEDS)
    • 6.2.1.1 Semi-Automated External Defibrillators
    • 6.2.1.2 Fully Automated External Defibrillators
  • 6.3 Manual External Defibrillators
  • 6.4 Wearable Cardioverter Defibrillators (WCDS)

7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.5.1 Brazil
    • 7.5.2 Argentina
  • 7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 a€" 2025

8 GLOBAL DEFIBRILLATORS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Medtronic PLC
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 St. Jude Medical, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Boston Scientific Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Philips Healthcare
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Zoll Medical Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Biotronik Se & Co.Kg
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Physio-Control International, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Cardiac Science Corporation
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sorin Group
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Nihon Kohden Corporation
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Reports